A study led by the Institute of Bioengineering of Catalonia demonstrates that laminin, a protein present in breast tissues, prevents the effects of stiffening, protecting cells against tumor growth. While the mechanism has been demonstrated in vitro, persuasive indications suggest its potential applicability in vivo, as observed in patient samples.
Ref: FPI_CR/Deadline:17/11/2023
Ref: FPI_GG /Deadline: 31/10/2023
Ref: FPI_PG/ Deadline: 18/12/2023
Ref: FPI_LR // Deadline: 25/02/2024
Conserved nucleocytoplasmic density homeostasis drives cellular organization across eukaryotes Simone Reber, Max Planck Institut for Infection Biology, Berlin (invited by Pere Roca-Cusachs) The packing and confinement of macromolecules in the … Read more
New technologies for accelerating drug discovery and preclinical testing Maria Majellaro, Chief Scientific Officer of Celtarys. Abi J Vazquez. Co-founder and COO of DIVERSA Technologies SL. Bruno K Rodiño-Janeiro, Chief … Read more
The NanoBio&Med2023 is going to present the most recent international developments in the field of Nanobiotechnology and Nanomedicine and will provide a platform for multidisciplinary communication, new cooperations and projects to participants … Read more
We are delighted to announce the first edition of the symposium “The Future Now: Emerging Leaders in Biomedicine“. This event is specifically tailored for advanced postdoctoral researchers and junior Group … Read more